Benefits
Rapid ketosis and alternative brain fuel
goBHB® raises blood BHB concentrations to 0.5–1.5 mmol/L within 30–60 minutes — mimicking the metabolic state of 12–16 hours of fasting without dietary restriction. BHB is readily transported across the blood-brain barrier via MCT transporters, providing an efficient alternative fuel for neurons that can supplement or substitute glucose, supporting mental clarity, focus, and sustained cognitive energy.
Appetite suppression and satiety
Elevated BHB levels suppress ghrelin (the primary hunger hormone) and modulate hypothalamic appetite-regulating circuits. The human appetite data come from a single acute crossover trial in 15 normal-weight adults, and it used a ketone ester, not the salts sold here: one ester drink lowered ghrelin and self-reported hunger for a few hours versus a dextrose drink. No trial shows that ketone salts reduce body weight, and a short-term drop in hunger is not weight loss.
Exercise performance: no benefit shown for the salts
Controlled trials of exogenous ketones have not shown a performance benefit. A 2026 randomized trial of high-dose ketone monoester in recreational runners found no change in 5-km time-trial performance, and studies of ketone salts specifically are largely null, partly because the doses that raise ketones often cause nausea and stomach upset that hurt exercise rather than help it. The claim that these salts spare glycogen or improve endurance is not supported.
Anti-inflammatory signaling (laboratory studies only)
BHB acts as a signaling molecule beyond its fuel role — inhibiting the NLRP3 inflammasome, suppressing NF-κB inflammatory signaling, and activating HDAC inhibitor pathways that upregulate neuroprotective genes. These effects come from cell and animal studies, not from trials in people taking these salts. They are mechanisms of interest, not demonstrated benefits, and goBHB is a food supplement, not a treatment for any brain condition.
Mechanism of action
Mitochondrial beta-oxidation fuel substrate
BHB is converted to acetyl-CoA in mitochondria via SCOT and thiolase enzymes, entering the TCA cycle to produce NADH and FADH2 for oxidative phosphorylation. This metabolic pathway generates 10.5 ATP per BHB molecule — more efficiently than glucose (10 ATP) per equivalent oxygen consumption, explaining the performance and cognitive benefits of ketone supplementation.
NLRP3 inflammasome inhibition
BHB directly inhibits the NLRP3 inflammasome complex through interaction with NACHT domain — blocking the caspase-1 activation that drives IL-1β and IL-18 production. This anti-inflammatory mechanism, combined with HDAC inhibitor activity that upregulates FOXO3a and MT2 antioxidant genes, explains the neuroprotective and anti-aging properties associated with ketogenic states.
Clinical trials
Acute randomized crossover trial in 15 normal-weight adults comparing a ketone ester drink to an isocaloric dextrose drink for effects on appetite hormones and hunger. Ketone ester, not the salts sold here. (Stubbs et al. 2018, Obesity (Silver Spring))
15 normal-weight adults. Single acute dose, crossover.
The ester drink raised blood BHB from 0.2 to 3.3 mmol/L and lowered plasma ghrelin, self-reported hunger, and desire to eat for a few hours versus the dextrose drink. This was an acute study using a ketone ester, which reaches far higher ketone levels than the salts sold here, so the effect may not transfer to goBHB, and appetite suppression over one afternoon is not weight loss.
Six-week controlled-feeding trial in overweight and obese adults on a hypocaloric ketogenic diet, given a ketone salt (n=12) or a mineral-free placebo (n=13). The salt was added on top of a ketogenic diet, so its effect cannot be separated from the diet, and the study was funded by the supplement's maker. (Kackley et al. 2022, Front Neurosci)
25 overweight and obese adults on a ketogenic diet (12 salt, 13 placebo).
Both ketogenic-diet groups reached ketosis. The main finding was on mood: at week 2 the salt group had lower depression and anger scores than the mineral-free placebo group. Cognitive results were small and mixed, and the study concluded there was no consistent decline in either group. Any signal here belongs to the ketogenic diet plus salt together, not to the salt alone, and salts raise blood ketones only modestly, about 0.3 to 1.0 mmol/L.